Lauren Kriss
Comptroller/Controller/Auditor at RALLYBIO CORPORATION
Network origin in Lauren Kriss first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lauren Kriss via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Major Banks | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Director of Finance/CFO | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Private Equity Analyst | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| Tufts University | College/University | Graduate Degree Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Private Equity Investor Consultant / Advisor | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Founder Consultant / Advisor | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
| American Society of Clinical Psychopharmacology | President | ||
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| PREMIER, INC. | Hospital/Nursing Management | Director/Board Member | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Cruz Blanca Initiative, Inc. | Founder | ||
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARVINAS, INC. | Biotechnology | Director/Board Member | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| 5AM Partners V LLC | Corporate Officer/Principal | ||
| EVAXION BIOTECH A/S | Biotechnology | Director/Board Member | |
| SHATTUCK LABS, INC. | Biotechnology | Director/Board Member | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Founder Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Rallybio Holdings LLC
 Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Rallybio Holdings LLC engages in the provision of healthcare services. The company is headquartered in New Haven, CT. | Medical/Nursing Services | Chief Executive Officer Director/Board Member Director/Board Member | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | President Director/Board Member | |
| 501 ACQU | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Founder Chairman | |
Field Trip Health, Inc.
 Field Trip Health, Inc. Medical/Nursing ServicesHealth Services Field Trip Health, Inc. operates as mental wellness firm. It offers ketamine-enhanced psychotherapy and psychedelic medicine services. The company was founded by Ronan Levy, Joseph del Moral, Hannan Fleiman, Mujeeb Jafferi, and Ryan Yermus on November 1, 2019 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Director/Board Member | |
| AKOUOS | Biotechnology | Director/Board Member | |
| 5am Partners Vi LLC | Corporate Officer/Principal | ||
| ENTRADA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| VOR BIOPHARMA INC. | Biotechnology | Chief Executive Officer | |
Immuneel Therapeutics Pvt Ltd.
 Immuneel Therapeutics Pvt Ltd. Hospital/Nursing ManagementHealth Services Immuneel Therapeutics Pvt Ltd. operates as a cancer treatment center. The company was founded by Kiran Mazumdar-Shaw, Kush M. Parmar and Siddhartha Mukherjee is headquartered in Bengaluru, India. | Hospital/Nursing Management | Founder | |
| 5AM Opportunities I GP LLC | Corporate Officer/Principal | ||
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
Grace Science Foundation
 Grace Science Foundation Miscellaneous Commercial ServicesCommercial Services Grace Science Foundation is a biotechnology company that was founded in 2017 by Matt Wilsey and Dr. Carolyn Bertozzi. The private company is based in San Francisco, CA. The company focuses on developing novel therapies based on the function of NGLY1, a key enzyme involved in proteostasis. Grace Science Foundation's deep knowledge of the NGLY1 pathway enables them to identify new ways of treating NGLY1 deficiency as well as more common diseases. | Miscellaneous Commercial Services | Consultant / Advisor | |
Precede Biosciences, Inc.
 Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United States | 43 |
| India | 3 |
| Ireland | 2 |
| Denmark | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 24 |
| Commercial Services | 7 |
| Finance | 6 |
| Consumer Services | 6 |
| Health Services | 5 |
Operational
| Director/Board Member | 96 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 39 |
| Undergraduate Degree | 15 |
| Director of Finance/CFO | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Kush Parmar | 32 |
| Ron Hunt | 29 |
| Martin MacKay | 28 |
| Helen Boudreau | 22 |
| Robert Hopfner | 20 |
| Jonathan Lieber | 16 |
| Paula Soteropoulos | 13 |
| Lucian Iancovici | 13 |
| Christine Nash | 10 |
| Wendy Chung | 10 |
| Steven Ryder | 8 |
| Michael V. Greco | 8 |
| Stephen Uden | 5 |
| Liu Hui | 5 |
| Zhiliang Cheng | 3 |
- Stock Market
- Insiders
- Lauren Kriss
- Company connections
